Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Downgrades Trex Co to Underperform

Credit Suisse analyst Daniel Oppenheim downgrades Trex Co (NYSE:TREX) from Neutral to Underperform.

byBenzinga Newsdesk

October 14, 2022

1 minute read

Credit Suisse analyst Daniel Oppenheim downgrades Trex Co (NYSE:TREX) from Neutral to Underperform.

After Initial Skepticism FDA’s Adcomm Backs Amylyx’s Amyotrophic Lateral Sclerosis Hopeful

By Vandana Singh

September 8, 10:19 AM

The FDA Peripheral and Central Nervous System Drugs Advisory Committee voted (7 yes and 2 no) that the…

AMLX

SVB Leerink Maintains Market Perform on Regenxbio, Lowers Price Target to $43

By Benzinga Newsdesk

November 3, 5:23 AM

SVB Leerink analyst Mani Foroohar maintains Regenxbio (NASDAQ:RGNX) with a Market Perform and lowers the price target from $44 to $43.

RGNX

Key Takeaways From White House Chip Crisis Meet

By Anusuya Lahiri

September 24, 7:11 AM

The Biden government urged the semiconductor companies for “more transparency” about their supply chains at the White House…

AAPL

Why XPeng Stock Is Trading Lower Today

By Adam Eckert

April 11, 8:50 AM

XPeng Inc (NYSE: XPEV) shares are trading lower Monday morning following a report indicating total vehicle sales in China were significantly lower month-over-month.

XPEV

Credit Suisse Downgrades Trex Co to Underperform

Related Posts

After Initial Skepticism FDA’s Adcomm Backs Amylyx’s Amyotrophic Lateral Sclerosis Hopeful

SVB Leerink Maintains Market Perform on Regenxbio, Lowers Price Target to $43

Key Takeaways From White House Chip Crisis Meet

Why XPeng Stock Is Trading Lower Today